Neuronetics Inc. (STIM) - חוב להון עצמי

This daily price action for Neuronetics, Inc. (STIM) illustrates a total debt-to-equity ratio of 4.78. Neuronetics, Inc. (STIM) is expanding partnerships with medical centers by implementing its technologies through educational courses. The business leverages its status as a global leader in non-drug depression therapy via the NeuroStar system. High barriers to entry are maintained by patents, FDA certification, and the complexity of replacing equipment within clinics.

For Neuronetics, Inc. (STIM), the balance of borrowed funds is critical when scaling its network of transcranial stimulation clinics. This ratio is calculated as total liabilities to net equity, measuring the degree of financial leverage. By analyzing the debt-to-equity ratio on GURU.Markets, an investor can see the business's actual dependence on creditors. The trend line reflects the stability of the financing structure supporting the expansion. Low leverage confirms the company's autonomy in its development.